logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Tetracaine CAS 94-24-6 API Active Pharmaceutical Ingredient

Tetracaine CAS 94-24-6 API Active Pharmaceutical Ingredient

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 94-24-6

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15DAY

Payment Terms: L/C,D/P,D/A,T/T,Western Union,MoneyGram

Supply Ability: G,KG,TON

Get Best Price
Highlight:

Tetracaine CAS 94-24-6

,

CAS 94-24-6

Appearance::
White Crystalline Powder
CAS NO::
94-24-6
Molecular Formula::
C15H24N2O2
Molecular Weight::
264.36300
EINECS NO::
202-316-6
MDL NO::
MFCD00053787
Appearance::
White Crystalline Powder
CAS NO::
94-24-6
Molecular Formula::
C15H24N2O2
Molecular Weight::
264.36300
EINECS NO::
202-316-6
MDL NO::
MFCD00053787
Tetracaine CAS 94-24-6 API Active Pharmaceutical Ingredient

Product Description:

Product Name: Tetracaine CAS NO: 94-24-6


Synonyms:

2-(d-imethylamino)ethyl 4-(butylamino)benzoate;

Pontocaine;

Uromucaesthin;


Chemical & Physical Properties:

Appearance: White crystalline powder

Assay :≥99.00%

Density: 1.044 g/cm3

Boiling Point: 389.4℃ at 760 mmHg

Flash Point: 189.3℃

Refractive Index: 1.537

Storage Condition: 2-8℃

Water Solubility: 156mg/L(temperature not stated)


Safety Information:

RTECS: DG4725000

Safety Statements: S22-S36/37

HS Code: 2922499990

RIDADR: UN 2811

Risk Statements: R22; R40; R42/43

Hazard Codes: Xn,Xi

Hazard Class: 6.1

Packing Group: III


2-(d-imethylamino)ethyl 4-(butylamino)benzoate is used in assessing the potential for drug-nanoparticle surface interactions to improve drug penetration into the skin. Tetracaine is a local anesthetic or numbing medicine that is used to numb the throat, eyes, or nose. Normally, the drug is administered before starting a surgery to decrease pain from the procedure. Tetracaine is applied to the eyes 30 minutes before the start of an intravenous and its effects can last up to 15 minutes.


If you are interested in our products or have any questions, please feel free to contact us!


Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.